logo
COVID-19 (6m-4y) vaccine, Pfizer (2023-2024)

COVID-19 (6m-4y) vaccine, Pfizer (2023-2024)

Active Ingredients
COVID-19 (6m-4y) vaccine, Pfizer (2023-2024)
Drug Classes
Viral vaccines
logo
Scoring is done by our AI based assistant on the data from the FDA and other sources

7.8

/

10

Effectiveness
Safety
Addiction
Ease of Use
Contraindications
Top Conditions of COVID-19 (6m-4y) vaccine, Pfizer (2023-2024)
HeadacheSore ThroatSunburnBack PainWeight Loss (Obesity/Overweight)Cardiac ArrestBrain TumorCOVID-19Muscle PainCoughFatigueNeck Pain
Top Alternatives of Ibuprofen
By Action
8.5
Engerix-B Pediatric
8.5
COVID-19 (5y-11y) vaccine, Pfizer (2023-2024)
8.5
Afluria
8.5
Dengvaxia
8.5
COVID-19 (12y+) vaccine Spikevax (2023-2024)
8.5
Flublok Quadrivalent
Browse Drugs by Alphabet